Most Recent

image: Opinion: Understanding and Coping With Rising Publication Costs

Opinion: Understanding and Coping With Rising Publication Costs

By M. Bishr Omary and Theodore S. Lawrence | September 1, 2017

As article processing charges top $5,000 at some research journals, authors and institutions have means of negotiating better deals or finding less expensive options.


image: Opinion: Why I Published in a Predatory Journal

Opinion: Why I Published in a Predatory Journal

By John H. McCool | April 6, 2017

Our totally bogus case report swiftly passed muster, with only minor revisions requested.


Measuring PD-L1 levels was a great start. Now we need to quantify more protein biomarkers, assess the tumor mutational landscape, and examine immune cell signatures, too.


image: Pet Scans

Pet Scans

By Timothy M. Fan, Amy K. LeBlanc, and Nicola Mason | April 1, 2016

Studying tumor development and treatment in dogs and cats, in parallel with research on rodents and humans, could improve the successful translation of new cancer drugs.


image: Control ALT, Delete Cancer

Control ALT, Delete Cancer

By Haroldo Silva, David Halvorsen, and Jeremy D. Henson | April 1, 2015

Treating cancer by shutting down the alternative lengthening of telomeres (ALT) pathway

1 Comment

image: The Challenges of Precision

The Challenges of Precision

By Adam Marcus | April 1, 2015

Researchers face roadblocks to treating an individual patient’s cancer as a unique disease.

1 Comment

image: Overspending on Overhead

Overspending on Overhead

By Viviane Callier | February 1, 2015

Federal research dollars are needlessly wasted as scientists spend more and more of their time trying to recoup operational costs.


image: Enhanced Enhancers

Enhanced Enhancers

By Eric Olson | November 1, 2014

The recent discovery of super-enhancers may offer new drug targets for a range of diseases.


image: Psychiatry: An SOS Call

Psychiatry: An SOS Call

By Robert E. Becker | May 1, 2014

Social policies shaped the practice of psychiatry in the past. As the discipline becomes ever more scientific, the effects of social policy on patient well-being must not be ignored.


image: Fighting Cancer with Nanomedicine

Fighting Cancer with Nanomedicine

By Dean Ho | April 1, 2014

Nanotechnology-based therapeutics will revolutionize cancer treatment.


Popular Now

  1. Could Rapamycin Help Humans Live Longer?
  2. Elena Rybak-Akimova, Chemical Kinetics Expert, Dies
  3. University of Oregon Erecting a $1-Billion Science Center
  4. <em>Homo Sapiens</em> Interbred With Denisovans From Two Different Populations